Home > National Drug Code (NDC) > REBIF REBIDOSE

REBIF REBIDOSE - 44087-3344-1 - (INTERFERON BETA-1A)

Alphabetical Index


Drug Information of REBIF REBIDOSE

Product NDC: 44087-3344
Proprietary Name: REBIF REBIDOSE
Non Proprietary Name: INTERFERON BETA-1A
Active Ingredient(s): 44    ug/.5mL & nbsp;   INTERFERON BETA-1A
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of REBIF REBIDOSE

Product NDC: 44087-3344
Labeler Name: EMD Serono, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA103780
Marketing Category: BLA
Start Marketing Date: 20121221

Package Information of REBIF REBIDOSE

Package NDC: 44087-3344-1
Package Description: 12 PACKAGE in 1 CARTON (44087-3344-1) > .5 mL in 1 PACKAGE (44087-3344-9)

NDC Information of REBIF REBIDOSE

NDC Code 44087-3344-1
Proprietary Name REBIF REBIDOSE
Package Description 12 PACKAGE in 1 CARTON (44087-3344-1) > .5 mL in 1 PACKAGE (44087-3344-9)
Product NDC 44087-3344
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name INTERFERON BETA-1A
Dosage Form Name INJECTION, SOLUTION
Route Name SUBCUTANEOUS
Start Marketing Date 20121221
Marketing Category Name BLA
Labeler Name EMD Serono, Inc.
Substance Name INTERFERON BETA-1A
Strength Number 44
Strength Unit ug/.5mL
Pharmaceutical Classes Interferon-beta [Chemical/Ingredient],Recombinant Human Interferon beta [EPC],Recombinant Proteins [Chemical/Ingredient]

Complete Information of REBIF REBIDOSE


General Information